Clinical trial of Methyl-prednisolone pulse conbined therapy for Refractory Kawasaki Disease: Trial in Single Institutio
Not Applicable
- Conditions
- Kawasaki diease
- Registration Number
- JPRN-UMIN000005021
- Lead Sponsor
- Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included a previous diagnosis, the presence of coronary artery aneurysms, and other contraindications to steroid therapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method First outcome defined a antipyretic potency at 36 hours after completion of the initial treatment.
- Secondary Outcome Measures
Name Time Method Second outcome defined a envaluation of coronary artery at 36 hours and 1 month after the end of thrapy.